Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Cycle Pharma Acquires Banner Life Sciences, LLC
Life Sciences Times
-
January 13, 2025
0
Venture Capital
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
Life Sciences Times
-
January 8, 2025
0
Venture Capital
Transcarent To Acquire Accolade
Life Sciences Times
-
January 8, 2025
0
Venture Capital
KARL STORZ Acquires Medical Business of Visual Collaboration Software Company T1V
Life Sciences Times
-
January 8, 2025
0
Venture Capital
Klick Health Acquires Peregrine Market Access
Life Sciences Times
-
January 7, 2025
0
Venture Capital
Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles
Life Sciences Times
-
January 6, 2025
0
Venture Capital
MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio
Life Sciences Times
-
January 6, 2025
0
Venture Capital
MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio
Life Sciences Times
-
December 18, 2024
0
People on the Move
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
Life Sciences Times
-
December 12, 2024
0
Venture Capital
Turn Therapeutics Secures $75 Million Investment Commitment Tied to Public Listing
Life Sciences Times
-
December 12, 2024
0
Venture Capital
Syncell Announces $15 Million Series A Funding
Life Sciences Times
-
December 11, 2024
0
Venture Capital
OpenClinica Acquires BuildClinical
Life Sciences Times
-
December 10, 2024
0
1
...
21
22
23
...
115
Page 22 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026